HCV non-structural protein mutants and uses thereof
AssigneeChiron Corporation
InventorsDavid Chien, Doris Coit, Celine Hu, Sansan Lin, Angelica Medina-Selby
Life of this patent
Estimating the term…
Abstract
Modified HCV non-structural proteins are described. The proteins include modified NS3 domains such that proteolytic activity of the NS3 molecule is inhibited. The modified proteins retain conformational epitopes. HCV immunoassays including the modified NS3 molecules are also described.
Claims42
An immunoassay solid support comprising a polypeptide comprising a modified hepatitis C virus (HCV) NS3 protease domain such that protease activity of the modified NS3 polypeptide is inhibited relative to protease activity of a corresponding HCV NS3 polypeptide lacking the modification, wherein said polypeptide comprises an NS3 conformational epitope and reacts specifically with anti-HCV antibodies present in a biological sample from an HCV-infected individual.
An isolated polypeptide comprising the amino acid sequence of SEQ ID NO:2, wherein the polypeptide comprises an NS3 conformational epitope.
An isolated polypeptide comprising the amino acid sequence of SEQ ID NO:4, wherein the polypeptide comprises an NS3 conformational epitope.
An isolated polypeptide comprising the amino acid sequence of SEQ ID NO:6, wherein the polypeptide comprises an NS3 conformational epitope.
Dependencies are inferred from the claim text.